20519 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
Sub-classes:Akkermansia muciniphila MG784 for alleviating constipation,promoting defecation, improving intestinal barrier function and intestinal immunity, and its uses
#2COMPOSITIONS INCLUDING CAFFEIC ACID PHENETHYL ESTER
#3BIVALENT LECA INHIBITORS TARGETING BIOFILM FORMATION OF PSEUDOMONAS AERUGINOSA
#4PREPARATION OF NANO LINIMENT FOR EXTERNAL TREATMENT OF GOUT
#5METHOD OF TREATING GOUT BY TOPICAL APPLICATION OF NANO LINIMENT
#6BIPHASIC CHRONO-ADAPTIVE NUTRACEUTICAL SYSTEM FOR ENHANCED CIRCADIAN BIOAVAILABILITY
#7SOFT GUMMY
#8PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#9COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE AND LIVER FIBROSIS
#10INJECTABLE HYDROGEL FOR PET ENDOMETRITIS, AND PREPARATION METHOD AND USE THEREOF
#11CHRONIC WOUND HEALING COMPOSITION AND APPLICATION THEREOF
#12PHARMACEUTICAL COMPOSITION AND USE THEREOF
#13MYCONOSIDE-RICH EXTRACT FROM IN VITRO SYSTEMS OF PLANTS BELONGING TO GENERA HABERLEA AND RAMONDA, METHOD OF PREPARATION, AND USE AS CHEMO-, RADIO- AND UV PROTECTOR
#14PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#15GUT MICROBIOME BACTERIA AND ENZYMES THAT METABOLIZE DIETARY AND MEDICINAL PLANT SMALL MOLECULES TO AFFECT GUT MICROBIOME
#16COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES
#17LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF
#18Composition for enhancing exercise performance, increasing muscle mass, improving muscle functions, or preventing or treating muscular disease containing Polygonum multiflorum Thunberg extract
#19INVARIANT NATURAL KILLER T-CELL ACTIVATORS
#20ANTI-MALASSEZIA AGENT
#21COMPOSITION AND APPLICATION THEREOF
#22Pharmaceutical Composition for Promoting Neurogenesis and Method of Utilizing Gastrodia Elata Extract or Adenosine Analog for Promoting Neurogenesis
#23TOPICAL FORMULATIONS OF CYCLOOXYGENASE INHIBITORS AND THEIR USE
#24PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#25COMPOSITIONS AND METHODS FOR THE STIMULATION OF INTERMEDIATE MACROPHAGES AND TREATMENTS THEREWITH
#26FOOD SUPPLEMENT COMPRISING NEOHESPERIDIN DIHYROCHALCONE AND PEPPERMINT OIL
#27POLYMORPHIC FORM OF CHALCONE GLYCOSIDE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF
#28Method Of Treating Major Depressive Disorder
#29SAFFRON AS ANTI-INFLAMMATORY AGENT IN TREATING INFLAMMATORY BOWEL DISEASE
#30TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
#31APPLICATION OF PHD2 INHIBITOR IN PREPARATION OF DRUGS FOR PREVENTION AND TREATMENT OF PLATELET THROMBUS
#32COMPOSITIONS AND METHODS FOR ALLEVIATING ADVERSE EFFECTS FROM RESPONSIBLE ALCOHOL CONSUMPTION
#33COMBINATORIAL, AND ROTATIONAL COMBINATORIAL THERAPIES
#34NOVEL CANNABINOID DERIVATIVES
#35METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE
#36METHOD OF TREATING MAJOR DEPRESSIVE DISORDER
#37COMPOSITIONS AND METHODS FOR MODULATING NUCLEAR FACTOR OF ACTIVATED T-CELLS (NFAT) ACTIVITY OF T CELLS
#38METHODS AND COMPOSITIONS FOR TREATING DEMENTIA
#39Compounds for Anti-aging Intervention
#40Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections
#41TOPICAL ANALGESIC
#42LICORICE EXTRACT
#43SYSTEMS AND METHODS FOR THROMBOSIS PREVENTION
#44Compositions and Methods for Treating Bleeding and Bleeding Disorders
#45Active ingredient groups and their key target combinations for the treatment of UC
#46COMPOSITION FOR IMPROVING, PREVENTING, OR TREATING SLEEP DISORDERS COMPRISING DENDROPANAX MORBIFERA EXTRACTS
#47A PHARMACEUTICAL COMPOSITION COMPRISING COMBINATION OF SGLT2 INHIBITOR AND DPP-IV INHIBITOR
#48RHODIOLA ROSEA NANOEMULSION AND PREPARATION METHOD THEREOF
#49Mammalian ATG8 Proteins and ATG9A Direct Sealing of Autophagosomal Membranes
#50WILLOW EXTRACT AND ITS USE IN TREATING A VIRAL INFECTION, ALLERGIC REACTION, AND OTHER MEDICAL CONDITIONS
#51COMPOSITE COMPOSITION CONTAINING ANGIOTENSIN RECEPTOR BLOCKER AND SGLT2 INHIBITOR
#52COMPOUND FOR TREATING NEURODEGENERATIVE DISEASES AND ITS ISOLATION METHOD THEREOF
#53METHODS FOR PREVENTING AND TREATING ACUTE KIDNEY INJURY
#54USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CARDIAC DISEASES IN NON-HUMAN MAMMALS EXCLUDING FELINES, IN PARTICULAR CANINES
#55CHOLESTOSOME VESICLES FOR INCORPORATION OF MOLECULES INTO CHYLOMICRONS
#56EXTERNAL NANO LINIMENT FOR GOUT AND PREPARATION METHOD THEREOF
#57COMPOSITION OF TANNIC ACID AND VITAMIN D AND METHODS OF USE
#58Compositions and methods for alleviating adverse effects from responsible alcohol consumption
#59SUMO PATHWAY AS AN OXYGEN SENSOR RELEVANT TO THE PATHOPHYSIOLOGY OF PULMONARY ARTERY HYPERTENSION AND CARDIAC ARRHYTHMIA
#60COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES
#61COMPOSITIONS FOR ORAL CANCER OR AN OROPHARYNGEAL CANCER
#62Prophylactic and therapeutic drug for nonalcoholic fatty liver disease
#63Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections
#64USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF RENAL DISEASES IN NON-HUMAN MAMMALS
#65PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND PREPARATION COMPRISING GLUCOKINASE ACTIVATOR AND DPP-IV INHIBITOR, AND PREPARATION METHOD AND USE THEREOF
#66COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL HORMONE SUPPLEMENTATION
#67DRIED COSMETIC PREPARATION FOR REHYDRATION AND USE
#68TRANSLATION INHIBITOR WITHOUT OCCUPYING RIBOSOME RESOURCES AS ANTI-TUMOR DRUG
#69METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT
#70THERAPEUTIC AGENTS AND METHODS OF PRODUCING SAME
#71USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS
#72CREAM FOR TREATING ACNE AND MELASMA
#73PHARMACEUTICAL COMPOSITION FOR ENHANCING IMMUNITY OR ANTI-CANCER ACTIVITY INCLUDING EXTRACT OF PSEUDOLYSIMACHION NAKAIANUM (OHWI) T.YAMAZ AS ACTIVE INGREDIENT
#74ANTIOXIDANT COMPOSITION COMPRISING POLYDATIN AND ACETYLCYSTEINE
#75MEDICAMENT
#76WATER-SOLUBLE CANNABINOID FOOD AND BEVERAGE ADDITIVE HAVING ENHANCED STABILITY
#77SODIUM-DEPENDENT GLUCOSE TRANSPORTER 2 AS A DIAGNOSTIC AND THERAPEUTIC TARGET FOR PRE-MALIGNANT LESIONS
#78Application of Inhibitors Targeting CD226 Molecules in Anti-Tumor Metastasis
#79COMPOSITIONS AND METHODS FOR MANAGING NEPHROPATHY
#80LIGUSTRUM LUCIDUM EXTRACT USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN
#81COMPOUNDS AND PHARMACEUTICAL USES THEREOF
#82PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#83INHIBITORS OF SGLT-1 AND USES THEREOF
#84ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS
#85CREAM FOR TREATING ACNE AND MELASMA
#86PHARMACEUTICAL COMPOSITION FOR TREATMENT OF NEUROINFLAMMATION, COMPRISING ELEUTHEROSIDE B AS ACTIVE INGREDIENT
#87HIGH-PURITY STEVIOL GLYCOSIDES
#88DENDROBIUM FIMBRIATUM EXTRACT AND NO-RINSE COSMETIC COMPOSITION COMPRISING SAME
#89Method Of Treating Major Depressive Disorder
#90Method Of Treating Major Depressive Disorder
#91Method of treating major depressive disorder
#92PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#93SEMICARBAZONE-BASED SAPONIN CONJUGATE
#94COMBINATION THERAPIES FOR TREATMENT OF CIRRHOSIS WITH PORTAL HYPERTENSION
#95Compositions And Methods For Inducing Apopotosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections
#96USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES
#97BIOACTIVE COMPOUNDS EXTRACTION FROM PLANT MATTERS OF SILYBUM MARIANUM AND USAGE
#98NOVEL USES
#99METHODS OF MOBILIZING MARROW INFILTRATING LYMPHOCYTES AND USES THEREOF
#100METHODS FOR LOWERING HBA1C LEVEL WITH A COMBINATION OF A BET BROMODOMAIN INHIBITOR AND A SODIUM DEPENDENT GLUCOSE TRANSPORT 2 INHIBITOR
#101PHARMACEUTICAL COMPOSITIONS WITH LOW AMOUNTS OF NITROSAMINE IMPURITIES AND METHODS FOR PRODUCING THE SAME
#102AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS
#103Methods of preparing steviol glycosides and uses of the same
#104VETERINARY PHARMACEUTICAL FORMULATIONS
#105FORMULATIONS COMPRISING BOTANICAL EXTRACTS
#106HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS
#107AUTOPHAGY ACTIVATOR
#108Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases
#109AUTOPHAGY ACTIVATOR
#110CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS
#111COMPOSITION AND USE OF SGLT-2 INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKERS
#112PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND PREPARATION CONTAINING GLUCOKINASE ACTIVATOR AND K-ATP CHANNEL BLOCKER, PREPARATION METHOD THEREFOR AND USE THEREOF
#113USE OF SGLT-2 INHIBITORS IN THE DRYING-OFF OF NON-HUMAN MAMMALS
#114A PHARMACEUTICAL FORMULATION TO TREAT ACUTE AND CHRONIC PANCREATITIS
#115COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR REGROWTH
#116MULTIPLE MEDIATORS TARGETED MULTIFUNCTIONAL NANOPARTICLES AND USES THEREOF
#117METHODS FOR TREATMENT OF POST-SURGERY LAXITY OF TENDONS AND TENDON REPAIR
#118METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS WITH DOUBLE AND TRIPLE COMBINATIONS OF ANTIVIRAL AND IMMUNE MODULATING COMPOUNDS
#119COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPase
#120PHARMACEUTICAL COMPOSITION COMPRISING PALMITOYLETHANOLAMIDE AND L-ACETYLCARNITINE
#121Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons
#122A COMPOSITION COMPRISING AN EXTRACT OF ALDER TREE OR THE ISOLATED COMPOUNDS THEREFROM FOR TREATING AND PREVENTING SKELETON MUSCLE-RELATED DISORDER AND THE USE THEREOF
#123Method for prevention or treatment of amyotrophic lateral sclerosis by administering gastrodin
#124COMPOSITE FORMULATION COMPRISING SITAGLIPTIN AND DAPAGLIFLOZIN AND PREPARATION METHOD THEREFOR
#125CANNABINOID AND SUGAR ALCOHOL COMPLEX, METHODS TO MAKE AND USE
#126Topical formulations of cyclooxygenase inhibitors and their use
#127Method of treating major depressive disorder
#128COMPOSITIONS AND METHODS FOR OVERCOMING MICROENVIRONMENT-MEDIATED RESISTANCE VIA E-SELECTIN TARGETING
#129Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof
#130COMBINATION OF FINERENONE AND A SGLT2 INHIBITOR FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR AND/OR RENAL DISEASES
#131COMPOSITIONS AND METHODS FOR JOINT HEALTH
#132DRUG DELIVERY SYSTEM BASED ON CALCIUM PHOSPHATE NANOPARTICLES FUNCTIONALIZED WITH BIOACTIVE COMPOUNDS FROM EUPHORBIA EXTRACT AND THE USES THEREOF
#133METHODS FOR PREVENTING, REVERSING OR TREATING A COVID-19 INFECTION
#134Methods and Compositions for Treatment of Cystic Fibrosis Class I Mutations
#135ANTIBACTERIAL PRODUCTS
#136COMPOUNDS AND METHODS FOR REDUCTION OF CANCER CELL BURDEN AND PROTECTION OF NORMAL HEMATOPOIESIS
#137CALORIC RESTRICTION MIMETIC COMPOSITIONS
#138ORAL COMPLEX TABLET COMPRISING SITAGLIPTIN, DAPAGLIFLOZIN, AND METFORMIN
#139TREATMENT OF METABOLIC DISORDERS IN FELINE ANIMALS
#140LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF
#141COMBINATION OF T-CELL CHECKPOINT INHIBITORS WITH INHIBITORS OF E-SELECTIN OR CXCR4, OR WITH HETEROBIFUNCTIONAL INHIBITORS OF BOTH E-SELECTIN AND CXCR4
#142THERAPEUTIC OR PROPHYLACTIC METHOD FOR DIABETES USING COMBINATION MEDICINE
#143Pemafibrate dosing regimens
#144Method for producing a polyphenolic composition from barley malt
#145E-selectin antagonist compounds, compositions, and methods of use
#146ANTIMICROBIAL BLADDER ADDITIVES SYSTEM AND METHOD
#147CHRONIC WOUND HEALING COMPOSITION AND APPLICATION THEREOF
#148DERMATOLOGICAL COLLAR FOR NON-HUMAN ANIMALS
#149COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#150COMBINATION THERAPY USING GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF OBESITY
#151Novel Immunodulating Small Molecules
#152COMPOSITION OF N-PALMITOYL-ETHANOLAMIDE AND BAICALEIN IN CO-MICRONIZED FORM
#153BIVALENT LECA INHIBITORS TARGETING BIOFILM FORMATION OF PSEUDOMONAS AERUGINOSA
#154TUCARESOL DERIVATIVES AND USES THEREOF
#155Topical analgesic
#156TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS
#157TOPICAL FORMULATIONS OF CYCLOOXYGENASE INHIBITORS AND THEIR USE
#158COMPOUNDS AND METHODS FOR TREATING OR PREVENTING CARDIOVASCULAR DISEASES AND CONDITIONS
#159METHODS OF TREATING LIPEDEMA INCLUDING AKR1C1 AS A THERAPEUTIC TARGET
#160Application of tannic acid in preparation of medicament against respiratory viruses
#161BIOMATERIAL-BASED ANTIGEN FREE VACCINE AND THE USE THEREOF
#162Systems and methods for thrombosis prevention
#163METHOD OF PREPARING PENTACYCLIC TRITERPENOID SAPONINS AND DRUG COMPOSITION
#164Willow extract and its use in treating a viral infection, allergic reaction, and other medical conditions
#165Composition and use thereof in the manufacture of medicament for treating cancer
#166PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#167Drug Delivery Composition Comprising a Self-Assembled Gelator
#168Pemafibrate dosing regimens
#169GENETICALLY MODIFIED HOST CELLS PRODUCING GLYCOSYLATED CANNABINOIDS
#170Method of treating oxidative stress due to radiation exposure
#171METHODS FOR USE OF GENE EXPRESSION AS AN INDICATOR OF E-SELECTIN INHIBITOR EFFICACY AND CLINICAL OUTCOME FOR MULTIPLE TUMOR TYPES
#172Pemafibrate dosing regimens
#173CYCLODEXTRIN BASED INJECTABLE COFORMULATIONS OF SGLT2 INHIBITORS AND INCRETIN PEPTIDES
#174CHITIN ANALOGS FOR THE TREATMENT OF KIDNEY DISEASES
#175MIXTURE OF INOSITOL DERIVATIVES
#176Method of treating focal segmental glomerulosclerosis
#177Compounds and pharmaceutical uses thereof
#178IONTOPHORESIS ADMINISTRATION DEVICE
#179COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)
#180COMPOSITIONS HAVING THE ABILITY TO PROMOTE HEALTHY CHOLESTEROL LEVELS
#181CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS
#182HIGH-PURITY STEVIOL GLYCOSIDES
#183seed extract composition and its application in antibiotic-resistant infections
#184ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS
#185PHARMACEUTICAL COMPOSITION AND METHOD FOR NEOANGIOGENESIS/REVASCULARIZATION USEFUL IN TREATING ISCHEMIC HEART DISEASE
#186COMPOSITIONS AND THERAPEUTIC METHODS
#187Mannose derivatives for treating bacterial infections
#188Method of treating major depressive disorder
#189Methods and compositions relating to the treatment of fibrosis
#190Antioxidant composition comprising polydatin and acetylcysteine
#191Composition for the treatment of COVID-19
#192Methods of preparing steviol glycosides and uses of the same
#193USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS
#194ACYLATED COMPOUNDS FOR THE TREATMENT OF OCULAR PATHOLOGIES
#195COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE
#196Prophylactic and therapeutic drug for nonalcoholic fatty liver disease
#197Method for maintaining the health of a diabetic patient by preventing the occurrence of diabetic ketoacidosis
#198Method for separating phenolic acid glucoside compounds from
#199Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons
#200Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases
#201SOLID GLP-1 DERIVATIVE COMPOSITIONS FOR ORAL ADMINISTRATION
#202METHODS FOR TREATMENT OF POST-SURGERY LAXITY OF TENDONS AND TENDON REPAIR
#203METHODS OF TREATMENT ASSOCIATED WITH ENDOVASULAR GRAFTS
#204Topical analgesic
#205Therapeutic agents and methods of producing same
#206METHOD FOR REDUCING DRUG-INDUCED NEPHROTOXICITY
#207Nanoparticle delivery system for targeted anti-obesity treatment
#208Pharmaceutical composition, methods for treating and uses thereof
#209APPLICATION OF GLYCOSIDES IN THE PREPARATION OF DRUGS FOR PREVENTING AND TREATING DIABETES COMPLICATIONS
#210Highly potent multimeric e-selectin antagonists
#211Compositions comprising resveratrolosides and curcumins
#212NOVEL TLR4 INHIBITORS FOR THE TREATMENT OF HUMAN INFECTIOUS AND INFLAMMATORY DISORDERS
#213N-palmitoyl-D-glucosamine in a micronized form
#214Pharmaceutical composition, methods for treating and uses thereof
#215Compositions for oral cancer or an oropharyngeal cancer
#216COMPOSITIONS BASED ON ACTIVE PRINCIPLES OF PLANT ORIGIN HAVING EYE PROTECTION ACTION
#217PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#218ASCORBIC ACID, QUINONE COMPOUND, AND SODIUM GLUCOSE COTRANSPORTER INHIBITOR FOR TREATING CANCER
#219PHARMACEUTICAL COMPOSITION AND METHOD FOR NEOANGIOGENESIS/REVASCULARIZATION USEFUL IN TREATING ISCHEMIC HEART DISEASE
#220USE OF SALIDROSIDE AND DERIVATIVE THEREOF IN PREPARATION OF INHIBITOR MEDICAMENT FOR DISEASES OF OPHTHALMIC FIBROSIS CAUSED BY ABNORMALITIES OF EXTRACELLULAR MATRIX PROTEINS
#221Use of SGLT-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines
#222LOW-DOSE TRIPLE COMBINATION FORMULATION
#223Method of treating major depressive disorder
#224Formulation and process for modulating wound healing
#225PERITONEAL SODIUM-GLUCOSE TRANSPORTER (SGLT) INHIBITORS FOR IMPROVEMENT OF PERITONEAL DIALYSIS
#226Pharmaceutical combination, composition and compound preparation containing glucokinase activator and K-ATP channel blocker, preparation method therefor and use thereof
#227Pharmaceutical combination, composition, and combination preparation comprising glucokinase activator and SGLT-2 inhibitor and preparation methods and uses thereof
#228Pharmaceutical combination containing glucose kinase activator and PPAR receptor activator, composition, compound preparation method for same, and uses thereof
#229COMBINATIONS COMPRISING AN SSAO/VAP-1 INHIBITOR AND A SGLT2 INHIBITOR, USES THEREOF
#230Pharmaceutical Composition for Promoting Neurogenesis and Method of Utilizing Gastrodia Elata Extract or Adenosine Analog for Promoting Neurogenesis
#231METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT
#232USE OF TREZASTILBENOSIDE IN MANUFACTURE OF PRODUCT FOR TREATING AND/OR PREVENTING NON-ALCOHOLIC FATTY LIVER DISEASE
#233Use of trezastilbenoside in manufacture of product for treating and/or preventing disease of respiratory system
#234Pharmaceutical combination and composition, and combination preparation containing glucokinase activator and biguanide hypoglycemic drug as well as preparation method and use thereof
#235Pharmaceutical combination, composition and compound preparation comprising glucokinase activator and DPP-IV inhibitor, and preparation method and use thereof
#236Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
#237Compounds and methods for treating bacterial infections
#238Use of SGLT-2 inhibitors in the drying-off of non-human mammals
#239USES OF VERBASCOSIDE IN TREATMENT OF DIABETIC-ASSOCIATED KDINEY INJURY AND DIABETIC-ASSOCIATED LIVER INJURY
#240COMPOSITIONS AND METHODS FOR TREATING SEPTIC CARDIOMYOPATHY
#241Methods and compositions relating to the treatment of fibrosis
#242Compositions and methods for treatment of inflammatory disorders
#243COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#244COMPOSITION COMPRISING VEGETABLE EXTRACTS WITH FLAVONOIDS FOR ALLEVIATING THE MANY EFFECTS OF AIR POLLUTION ON THE SKIN
#245Glycan therapeutics and method of treating conditions associated with TMAO
#246ANTIPLATELET ACTIVITY OF THE ACANTHUS MOLLIS SEEDS' TOTAL EXTRACT AND ITS CONSTITUENTS
#247Compositions and Methods for Preventing or Treating Nephrolithiasis
#248Methods for skin whitening, ultraviolet radiation protection and suppression of glycation using green mango extracts and compounds obtained therefrom
#249TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
#250Use of verbascoside in preparation of drug for preventing or treating glomerular podocyte injured renal disease
#251Combination of Rhodiola and Astragalus for the treatment of neurodegenerative diseases
#252Systems and methods for thrombosis prevention
#253FOOD OR FEED COMPOSITION FOR IMPROVING COGNITIVE FUNCTION OR MEMORY COMPRISING EXTRACT OF DESALTED SALICORNIA EUROPAEA
#254USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS
#255COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2
#256E-selectin antagonist compounds, compositions, and methods of use
#257Topical analgesic
#258METHODS FOR TREATING INFLAMMATORY DISEASES
#259POLYDATIN PACLITAXEL COMPOSITION, AND APPLICATION IN PREPARING MEDICAMENT FOR PREVENTING AND TREATING GASTRIC CANCER
#260LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF
#261PROBIOTIC RECOLONISATION THERAPY
#262PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#263Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections
#264Pharmaceutical composition for preventing or treating diabetes, containing zinc salt, cyclo-hispro and antidiabetic drug as active ingredients
#265Nutraceutical composition for the activation of sirtuins with anti-aging/reverse-aging effect
#266METHODS FOR REDUCING THE WEIGHT LOSS OR INCREASING THE WEIGHT OF A FELINE IN NEED THEREOF
#267Use of chlorogenic acid in preparation of drug for treating chordoma
#268Methods of preparing steviol glycosides and uses of the same
#269Method of Treating Focal Segmental Glomerulosclerosis
#270Gastroretentive sustained release formulations of
#271COMPOSITION FOR IMPROVING INTESTINAL BARRIER FUNCTION
#272Low-dose triple combination formulation
#273Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages
#274COMPOSITION FOR REDUCING WEIGHT AND LOWERING LIPID, PREPARATION METHOD THEREFOR AND USE THEREOF
#2752,7-dibromospiro[fluorene-9,4′-piperidine] compounds
#276MIXTURE OF INOSITOL DERIVATIVES
#277Derivatives of amphotericin B
#278Compositions And Methods For Immunotherapy
#279COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPASE
#280TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
#281COMPOSITIONS AND METHODS FOR INCREASING PHYTOCHEMICAL BIOAVAILABLITY AND BIOACTIVITY
#282METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT
#283Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof
#284Dietary supplement for glycemia control and diabetes prevention
#285Treatment of metabolic disorders in feline animals
#286Method for producing a polyphenolic composition from barley malt
#287METHODS INVOLVING DOWNREGULATING APOBEC3B
#288Treatment of metabolic disorders in canine animals
#289Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
#290E-selectin antagonist compounds, compositions, and methods of use
#291Solid glp-1 derivative compositions for oral administration
#292COMPOSITIONS AND METHODS FOR THE MODULATION OF GUT SENSORY CELLS
#293Food supplements for use in the prophylaxis and treatment of migraine
#294Method of treating major depressive disorder
#295METHOD FOR INHIBITING MYOPIA AND APPLICATION IN PREPARING DRUG
#296Functionalized saccharides as anti-inflammatory agents
#297MEDICAMENT
#298Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease
#299Glycan therapeutics and related methods thereof
#300Glycan therapeutics and related methods thereof